GarcÃa-Serran, A.; Ordoño, J.; DeGregorio-Rocasolano, N.; Melià -Sorolla, M.; Odendaal, K.; MartÃ-Sistac, O.; Gasull, T.
Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice. Antioxidants 2023, 12, 1945.
https://doi.org/10.3390/antiox12111945
AMA Style
GarcÃa-Serran A, Ordoño J, DeGregorio-Rocasolano N, Melià -Sorolla M, Odendaal K, MartÃ-Sistac O, Gasull T.
Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice. Antioxidants. 2023; 12(11):1945.
https://doi.org/10.3390/antiox12111945
Chicago/Turabian Style
GarcÃa-Serran, Alexia, Jesús Ordoño, Núria DeGregorio-Rocasolano, Marc Melià -Sorolla, Karla Odendaal, Octavi MartÃ-Sistac, and Teresa Gasull.
2023. "Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice" Antioxidants 12, no. 11: 1945.
https://doi.org/10.3390/antiox12111945
APA Style
GarcÃa-Serran, A., Ordoño, J., DeGregorio-Rocasolano, N., Melià -Sorolla, M., Odendaal, K., MartÃ-Sistac, O., & Gasull, T.
(2023). Targeting Pro-Oxidant Iron with Exogenously Administered Apotransferrin Provides Benefits Associated with Changes in Crucial Cellular Iron Gate Protein TfR in a Model of Intracerebral Hemorrhagic Stroke in Mice. Antioxidants, 12(11), 1945.
https://doi.org/10.3390/antiox12111945
